Formocortal
Clinical data | |
---|---|
Other names | 3-(2-chloroethoxy)-6-formyl-9α-fluoropregna-3,5-diene-11β,16α,17,21-tetrol-20-one 21-acetate |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C29H38ClFO8 |
Molar mass | 569.06 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Formocortal (INN), also known as fluoroformylone, is a corticosteroid used in dermatology[1] and ophthalmology.[2]
It was introduced in around 1970[1] and is not known to be marketed as of 2021.
See also
References
- 1 2 Aliperta, G.; Lattaro, R. (1971). "On the topical use of a new steroid, formocortal, in the treatment of phlebodermitis and in cutaneous auto- and homo-grafts". Minerva Cardioangiologica. 19 (11): 620–624. PMID 4942789.
- ↑ Marchese A, Bozzolasco M, Gualco L, Schito GC, Debbia EA (2001). "Evaluation of spontaneous contamination of ocular medications". Chemotherapy. 47 (4): 304–8. doi:10.1159/000048538. PMID 11399868. S2CID 33870589.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.